Evidence map›Paper›PMID 37263607›Full record

ArticleSouthern medical journal2023

STI Testing among Medicaid Enrollees Initiating PrEP for HIV Prevention in Six Southern States.

Paul Lanier, Susan Kennedy, Angela Snyder, Jessica Smith, Eric Napierala, Jeffrey Talbert, Lindsey Hammerslag, Larry Humble, Eddy Myers, Angel Whittington and 14 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Southern medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 1 country.

Paul LanierFrom the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Susan KennedyAcademyHealth, Washington, DC.
Angela SnyderGeorgia State University, Atlanta.
Jessica SmithGeorgia State University, Atlanta.
Eric NapieralaGeorgia State University, Atlanta.
Jeffrey TalbertUniversity of Kentucky, Lexington.
Lindsey HammerslagUniversity of Kentucky, Lexington.
Larry HumbleUniversity of Louisiana, Monroe.
Eddy MyersUniversity of Louisiana, Monroe.
Angel WhittingtonUniversity of Louisiana, Monroe.
Jheramy SmithUniversity of Louisiana, Monroe.
Marcus BachhuberLouisiana Department of Health, Baton Rouge.
Anna AustinFrom the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Thomas BlountFederal Advisory Partners, Arlington, VA.
Grace StehlinFrom the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Ana Lopez-De FedeUniversity of South Carolina, Columbia.
Hoa NguyenUniversity of South Carolina, Columbia.
Jean BruceVanderbilt University Medical Center, Nashville, Tennessee.
Carlos G GrijalvaVanderbilt University Medical Center, Nashville, Tennessee.
Sunita KrishnanAcademyHealth, Washington, DC.
Caitlin OtterAcademyHealth, Washington, DC.
Katie HortonThe George Washington University, Washington, DC.
Naomi SeilerThe George Washington University, Washington, DC.
William S PearsonCenters for Disease Control and Prevention, Atlanta, Georgia.
University of Louisiana at Monroe · USAcademyHealth · USGeorgia State University · USUniversity of North Carolina at Chapel Hill · USGeorge Washington University · USUniversity of Kentucky · USUniversity of South Carolina · USVanderbilt University Medical Center · USCenters for Disease Control and Prevention · USLouisiana State Department of Health and Hospitals · US

Funding

CDC HHS NU38OT000288
6 · The paper itself

Abstract

objectivesThe purpose of this study was to measure sexually transmitted infection (STI) testing among Medicaid enrollees initiating preexposure prophylaxis (PrEP) to prevent human immunodeficiency virus. Secondary data are in the form of Medicaid enrollment and claims data in six states in the US South.

methodsResearch partnerships in six states in the US South developed a distributed research network to accomplish study aims. Each state identified all first-time PrEP users in fiscal year 2017-2018 (combined N = 990) and measured the presence of STI testing for chlamydia, syphilis, and gonorrhea through 2019. Each state calculated the percentage of individuals with at least one STI test during 3-, 6-, and 12-month follow-up periods.

resultsThe proportion of first-time PrEP users that received an STI test varied by state: 37% to 67% of all of the individuals in each state who initiated PrEP received a test within the first 6 months of PrEP treatment and 50% to 77% received a test within the first 12 months.

conclusionsAlthough the Centers for Disease Control and Prevention recommends STI testing at least every 6 months for PrEP users, our analysis of Medicaid data suggests that STI testing occurs less frequently than recommended in populations at elevated risk of syphilis, gonorrhea, and chlamydia.

Indexed as

GonorrheaHIV InfectionsSexually Transmitted DiseasesSyphilisHomosexuality, MaleHumansMaleMedicaidUnited States

Identifiers

PMID37263607
PMCPMC10247181
OpenAlexW4378974666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.